SMO and rheumatoid arthritis: In addition, by coupling of G protein-coupled receptors, Smo modulates the activation of RhoA/ROCK (MYPT1) signaling through increasing/decreasing MLCP level to enhance/weaken traction force, which resulting in promoting/reducing RA-FLSs migration.